Loading...
Herceptin, Herzuma, Ogivri
Biologic • Anti-HER2 monoclonal antibody
Humanized antibody targeting HER2/neu receptor, inhibiting proliferation and inducing ADCC
Drug Class
Biologic
Subclass
Anti-HER2 monoclonal antibody
Half-life
28.5 days
Time for plasma concentration to decrease by 50%
Protein Binding
N/A
Fraction bound to plasma proteins
Therapeutic Index
Wide
Margin between therapeutic and toxic doses